Lecture

Towards Clinical Translation of Bioprinting

Description

This lecture covers the journey of Fabien Guillemot, a bioprinting pioneer, from a researcher to the founder of Poietis, a clinical 3D bioprinting company. It explores the development of Poieskin®, a lead candidate for tissue therapeutics, and the potential of Next-Generation Bioprinting in tissue engineering.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.